Symptoms and diagnosis of peptic

New Post Public Reply Private Reply Replies (0) Message Board
vivekwaghm
427
Symptoms and diagnosis of peptic ulcers

Peptic-Ulcers-e1586584124997.jpg

Peptic ulcers are open sores that develop inside the lining of the stomach and upper part of your small intestine (called the duodenum). Your stomach is protected by a thick layer of mucus to protect it from digestive juices. WE get ulcers when the protective layer is reduced.

There are two types of peptic ulcer:-

Gastric ulcers occur in your stomach.
Duodenal ulcers occur in the upper part of your small intestine.
Peptic ulcers are a common disease and can be a persistent problem. A healed ulcer can reoccur. A peptic ulcer can be caused due a bacterial infection bacterium Helicobacter pylori (H. pylori) and anti-inflammatory drugs. Stress and spicy food do not cause ulcers, though they can aggravate the symptoms.

Symptoms

Symptoms of peptic ulcers can vary, you may or may not have symptoms. Common symptoms of ulcer are:-

Burning pain in the stomach.
Feeling full, bloated or belching.
Intolerance for fatty food.
Heartburn.
Nausea
Your symptoms can worsen with an empty stomach. The pain may stop briefly when you have an anti-acid or after eating.

More severe symptoms of peptic ulcer include:-

Vomiting or vomit that appears red.
Dark, bloody stool or black stool.
Breathing problem.
Appetite changes.
Unexplained weight loss.
Book a gastroenterologist in Patna if you have any severe symptoms. You should also see the doctor if the over-the-counter anti-acids stop the pain temporarily.

Causes

Peptic ulcers are caused by an imbalance between the digestive fluid in your stomach (hydrochloric acid) and pepsin in your stomach and duodenum due to:-

Infection with a bacterium called Helicobacter pylori (H. pylori). Researchers are not sure how the bacteria spread. We can transmit it from person to person personal contact or from food and water.
Using nonsteroidal anti-inflammatory drugs (NSAID) such as Aspirin, ibuprofen, Naproxen, and celecoxib. These medicines can irritate the lining of your stomach and duodenum. Peptic ulcers are more common with the elderly who take pain medication or medication for osteoarthritis.
A condition called Zollinger-Ellison syndrome causes excessive production of stomach acid. Gastrinoma a tumor of the acid-producing cells increases the production of acid. Smoking, drinking alcohol, untreated stress, and eating spicy food make your ulcers more difficult to treat.
Diagnosis

The best gastroenterologist in Patna will start by looking at your medical history and performing a comprehensive medical examination. They may order the following tests:-

Upper endoscopy:- the gastroenterologist uses a tube equipped with a camera to probe your upper digestive tract.
A barium upper gastrointestinal GI X-ray is used to make the ulcer visible.
Laboratory tests to determine H. pylori bacteria through stool tests or blood tests at home, or breath tests. Doctors consider the breath test to be more accurate than blood tests. If you have the bacteria, your breath sample will contain radioactive carbon in the form of carbon dioxide.
Treatment

The best gastroenterologist in Patna will treat your peptic ulcers by suggesting lifestyle changes, prescribing medication or surgically.

They may prescribe:-

Antibiotics to kill H.pylori.
Proton pump inhibitors (PPI) reduces stomach acid by blocking the cells that produce acid. There are some side-effects of the medication.
Acid blockers to reduce acid production.
Anti-acids.
Medication to protect your stomach lining and intestine.
The gastroenterologist near me may perform a simple endoscopy procedure. They may opt to treat the ulcer surgically if there is a hole in the stomach or serious bleeding.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

PMGC Capital's Strategic Investment in Alaunos Therapeutics

Updated Category News Views 171

PMGC Capital LLC Plans to File Schedule 13D on Alaunos PMGC Capital LLC, a fully owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), has made a significant move in the financial landscape by announcing its intention to file a Schedule 13D with the U.S. Securities and Exchange Commission (SEC). This filing will disclose its beneficial ownership in Alaunos Therapeutics,...

Continue Reading
Black Diamond Therapeutics: Pivotal Developments Ahead

Updated Category News Views 97

Black Diamond Therapeutics Continues to Make Strides Recently, H.C. Wainwright confirmed a Buy rating on Black Diamond Therapeutics (NASDAQ: BDTX) shares, projecting a price target of $11.00. This positive outlook follows the company's major restructuring efforts aimed at advancing BDTX-1535, its leading drug candidate, into pivotal trials. This move is expected to not...

Continue Reading
Eureka Acquisition Corp Announces New Meeting Date and Deadlines

Updated Category News Views 187

Eureka Acquisition Corp's Important Announcement New York — Eureka Acquisition Corp (NASDAQ: EURK), a special purpose acquisition company, has recently made significant announcements regarding the schedule of its extraordinary general meeting. Originally set for June 20, it will now take place on June 25, providing shareholders with extra time for participation. Details...

Continue Reading
Diamedica Therapeutics Hits New Heights with $6.41 Stock Value

Updated Category News Views 118

Diamedica Therapeutics Inc. Achieves 52-Week High Diamedica Therapeutics Inc. (NASDAQ: DMAC) is making headlines as its stock has recently hit a remarkable 52-week high of $6.41. This impressive milestone comes amid a significant growth phase for the company, which is currently valued at around $230 million. The steep rise in the stock price over the past year indicates a...

Continue Reading
J.P. Morgan's Projections for 2025: Capital Market Insights

Updated Category News Views 6083

J.P. Morgan's Capital Market Assumptions for 2025 J.P. Morgan Asset Management has recently unveiled its 2025 Long-Term Capital Market Assumptions (LTCMAs), providing valuable insights into the anticipated returns and risks across various asset classes for the next decade. These projections serve as a compass for investment strategies, targeting institutional and...

Continue Reading